SMAP1、B3GAT2和RIMS1基因罕见变异与儿童静脉血栓栓塞症的关联
本研究对212个儿童静脉血栓栓塞症核心家系进行全基因组关联研究,随后用靶向二代测序寻找致病突变。三个单核苷酸多态性达到全基因组显著性,分别位于SMAP1和B3GAT2基因区域;rs2748331在儿童血栓栓塞性卒中样本中重复验证。靶向测序在24对不一致同胞对中发现SMAP1和RIMS1的预测有害变异。数据提示SMAP1、B3GAT2和RIMS1是儿童静脉血栓栓塞症的新易感位点,需进一步功能研究阐明分子机制。
要点
- 在212个儿童静脉血栓栓塞症核心家系中,三个单核苷酸多态性达到全基因组显著性,位于6q13区域SMAP1和B3GAT2基因。
- rs2748331在儿童血栓栓塞性卒中独立样本中重复验证(P=.00719),合并P=7.88×10-7。
- 靶向测序在24对不一致同胞对中发现SMAP1和RIMS1的预测有害编码变异,但传递不平衡检验未达统计学显著。
核心结论
- 数据提供有力证据表明SMAP1、B3GAT2和RIMS1是儿童静脉血栓栓塞症的新易感位点,并需未来功能研究揭示导致静脉血栓栓塞症的分子机制。
研究设计与样本
- 对212个儿童静脉血栓栓塞症核心家系进行全基因组关联研究,随后对24对不一致同胞对进行靶向二代测序。
主要发现
- 三个单核苷酸多态性通过100 000次自举置换检验确定的全基因组显著性阈值(P<10-5),位于染色体6q13上包含SMAP1和B3GAT2基因的区域。
- rs1304029与儿童静脉血栓栓塞症相关,未置换/置换后P值分别为1.42×10-6/2.0×10-6。
- rs2748331与儿童静脉血栓栓塞症相关,未置换/置换后P值分别为6.11×10-6/1.8×10-5。
- rs2748331在来自儿童血栓栓塞性卒中全基因组关联研究的独立样本中重复验证(P=.00719),合并P=7.88×10-7。
- 靶向二代测序在24对不一致同胞对中发现17个非同义编码变异,其中SMAP1中1个和RIMS1中3个被Protein Variation Effect Analyzer和/或sorting intolerant from tolerant评分预测为有害。
局限性
- 在全队列传递不平衡检验中,三个单核苷酸多态性未达统计学显著性:rs112439957(SMAP1)P=.08326、rs767118962(RIMS1)P=.08326、rs41265501(RIMS1)P=.05778。
- 作者指出需未来功能研究揭示导致静脉血栓栓塞症的分子机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent genome-wide association studies (GWAS) have confirmed known risk mutations for venous thromboembolism (VTE) and identified a number of novel susceptibility loci in adults. Here we present a GWAS in 212 nuclear families with pediatric VTE followed by targeted next-generation sequencing (NGS) to identify causative mutations contributing to the association. Three single nucleotide polymorphisms (SNPs) exceeded the threshold for genome-wide significance as determined by permutation testing using 100 000 bootstrap permutations (P < 10-5). These SNPs reside in a region on chromosome 6q13 comprising the genes small ARF GAP1 (SMAP1), an ARF6 guanosine triphosphatase-activating protein that functions in clathrin-dependent endocytosis, and β-1,3-glucoronyltransferase 2 (B3GAT2), a member of the human natural killer 1 carbohydrate pathway. Rs1304029 and rs2748331 are associated with pediatric VTE with unpermuted/permuted values of P = 1.42 × 10-6/2.0 × 10-6 and P = 6.11 × 10-6/1.8 × 10-5, respectively. Rs2748331 was replicated (P = .00719) in an independent study sample coming from our GWAS on pediatric thromboembolic stroke (combined P = 7.88 × 10-7). Subsequent targeted NGS in 24 discordant sibling pairs identified 17 nonsynonymous coding variants, of which 1 located in SMAP1 and 3 in RIMS1, a member of the RIM family of active zone proteins, are predicted as damaging by Protein Variation Effect Analyzer and/or sorting intolerant from tolerant scores. Three SNPs curtly missed statistical significance in the transmission-disequilibrium test in the full cohort (rs112439957: P = .08326, SMAP1; rs767118962: P = .08326, RIMS1; and rs41265501: P = .05778, RIMS1). In conjunction, our data provide compelling evidence for SMAP1, B3GAT2, and RIMS1 as novel susceptibility loci for pediatric VTE and warrant future functional studies to unravel the underlying molecular mechanisms leading to VTE.
引用
- Rühle F, Witten A, Barysenka A, et al. Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism. Blood. 2016. PMID: 28011674. doi:10.1182/blood-2016-07-728840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。